Role of PTEN in basal cell derived lung carcinogenesis

Molecular Carcinogenesis

Volumn 53, Issue 10, 2014, Pages 841-846

  Malkoski, Stephen P ^a,b   Cleaver, Timothy G ^a   Thompson, Joshua J ^a   Sutton, Whitney P ^a   Haeger, Sarah M ^a   Rodriguez, Karen J ^a   Lu, Shi Long ^a   Merrick, Daniel ^c   Wang, Xiao Jing ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Kras; Non small cell lung cancer; Squamous cell carcinoma

Indexed keywords

KRAS2 PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PTEN PROTEIN, MOUSE;

ADENOCARCINOMA; ANIMAL; ARTICLE; BASAL CELL CARCINOMA; C57BL MOUSE; GENE DELETION; GENETICS; HUMAN; KRAS; LUNG TUMOR; METABOLISM; MISSENSE MUTATION; MOUSE; NON-SMALL CELL LUNG CANCER; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE;

ADENOCARCINOMA; KRAS; NON-SMALL CELL LUNG CANCER; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; GENE DELETION; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION, MISSENSE; NEOPLASMS, BASAL CELL; PROTO-ONCOGENE PROTEINS P21(RAS); PTEN PHOSPHOHYDROLASE;

EID: 84908311796     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22030     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Giangreco A, Groot KR, Janes SM. Lung cancer and lung stem cells: Strange bedfellows? Am J Respir Crit Care Med 2007;175:547-553.
3. Sutherland KD, Berns A. Cell of origin of lung cancer. Mol Oncol 2010;4:397-403.
4. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121:823-835.
5. Xu X, Rock JR, Lu Y, et al. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc Natl Acad Sci U S A 2012;109:4910-4915.
6. Heist RS, Engelman JA. SnapShot: Non-small cell lung cancer. Cancer Cell 2012;21:448 e2.
7. Yamamoto H, Shigematsu H, Nomura M, et al. PIK3CA mutations and copy number gains in human lung cancers. Cancer Res 2008;68:6913-6921.
8. Spoerke JM, O'Brien C, Huw L, et al. Phosphoinositide 3-Kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models. Clin Cancer Res 2012;18:6771-6783. doi: 10.1158/1078-0432.CCR-12-2347 [Epub 2012 Nov 7].
9. Meuwissen R, Berns A. Mouse models for human lung cancer. Genes Dev 2005;19:643-664.
10. Ji H, Ramsey MR, Hayes DN, et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007;448:807-810.
11. Malkoski SP, Haeger SM, Cleaver TG, et al. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. Clin Cancer Res 2012;18:2173-2183.
12. Cho HC, Lai CY, Shao LE, Yu J. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma. Cancer Res 2011;71:7250-7258.
13. Xu X, Kobayashi S, Qiao W, et al. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest 2006;116:1843-1852.
14. Engelman JA, Chen L, Tan X, et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med 2008;14:1351-1356.
15. Yanagi S, Kishimoto H, Kawahara K, et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest 2007;117:2929-2940.
16. Jackson EL, Olive KP, Tuveson DA, et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res 2005;65:10280-10288.
17. Borczuk AC, Sole M, Lu P, et al. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-{beta} type II receptor. Cancer Res 2011;71:6665-6675. doi: 10.1158/0008-5472.CAN-11-1590 [Epub 2011 Sep 12].
18. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 2003;4:181-189.
19. Park KS, Liang MC, Raiser DM, et al. Characterization of the cell of origin for small cell lung cancer. Cell Cycle 2011; 10:2806-2815.
20. Rock JR, Onaitis MW, Rawlins EL, et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci U S A 2009;106:12771-12775.
21. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 2004;164:577-588.
22. Forrester E, Chytil A, Bierie B, et al. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res 2005;65:2296-2302.
23. Lesche R, Groszer M, Gao J, et al. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 2002;32:148-149.
24. Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001;410:1111-1116.
25. Caulin C, Nguyen T, Longley MA, Zhou Z, Wang XJ, Roop DR. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res 2004;64:5054-5058.
26. Wunderlich FT, Wildner H, Rajewsky K, Edenhofer F. New variants of inducible Cre recombinase: A novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility. Nucleic Acids Res 2001;29:E47.
27. Berton TR, Wang XJ, Zhou Z, et al. Characterization of an inducible, epidermal-specific knockout system: Differential expression of lacZ in different Cre reporter mouse strains. Genesis 2000;26:160-161.
28. Nikitin AY, Alcaraz A, Anver MR, et al. Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium. Cancer Res 2004;64:2307-2316.
29. Malkoski SP, Cleaver TG, Lu SL, Lighthall JG, Wang XJ. Keratin promoter based gene manipulation in the murine conducting airway. Int J Biol Sci 2010;6:68-79.
30. Wang S, Gao J, Lei Q, et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003;4:209-221.
31. Song MS, Salmena L, PandolfiPP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13:283-296.
32. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Ptendeficient tumorigenesis. Nature 2005;436:725-730.
33. Iwanaga K, Yang Y, Raso MG, et al. Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Cancer Res 2008;68:1119-1127.
34. Cole BB, Smith RW, Jenkins KM, Graham BB, Reynolds PR, Reynolds SD. Tracheal basal cells: A facultative progenitor cell pool. Am J Pathol 2010;177:362-376.
35. Ooi AT, Mah V, Nickerson DW, et al. Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. Cancer Res 2010;70:6639-6648.
36. Kumar PA, Hu Y, Yamamoto Y, et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 2011;147:525-538.
37. Farr AG, Braddy SC. Patterns of keratin expression in the murine thymus. Anat Rec 1989;224:374-378.